:: SIHL ::

Company Profile

Smart Quotes

INDOCO REMEDIES LTD.

NSE : INDOCOBSE : 532612ISIN CODE : INE873D01024Industry : Pharmaceuticals & DrugsHouse : Private

BSE293.008.05 (+2.83 %)

PREV CLOSE ( ) 284.95

OPEN PRICE ( ) 285.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2568

TODAY'S LOW / HIGH ( )285.00 299.25

52 WK LOW / HIGH ( )190 385.5

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1947

Management Info

Suresh G Kare - Chairman Aditi Panandikar - Managing Director

Registered Office

Address Indoco House,166 C S T Road,Kalina , Santacruz (East),
Mumbai,
Maharashtra-400098

Phone 022-62871000 / 68791250

Email compliance.officer@indoco.com

Website www.indoco.com

Registrar's Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

13Aug Indoco Remedies gets final nod for Riv
Indoco Remedies has received final approval of its Abbreviated New Drug..

13Aug Indoco Remedies soars on getting final
Indoco Remedies is currently trading at Rs. 296.80, up by 5.20 points or..

28Jul Indoco Remedies informs about earnings
Indoco Remedies has informed that it enclosed Transcript of Earnings Con..

24Jul Indoco Remedies gets Certificate of EU
Indoco Remedies has received Certificate for EU Good Manufacturing Pract..

24Jul Indoco Remedies informs about certific
Pursuant to Regulation 30 read with Part A of Schedule III of the Securi..

Financials

in Crores

	QTR Jun 25	ANNUAL 25
Net Profit	-28.06	-8.73
Gross Profit	-28.4	-7.37
Operating Profit	20.41	146.52
Net Sales	392.53	1518.19

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE) 5759.70 (8.15%)	M.Cap ( in Cr)26349.32
Neuland Laboratories (BSE) 13535.05 (2.04%)	M.Cap ( in Cr)17365.32
Astrazeneca Pharma I (BSE) 8413.05 (1.47%)	M.Cap ( in Cr)21032.63
Sanofi Cons. Health (BSE) 5242.55 (1.56%)	M.Cap ( in Cr)12073.92
Eris Lifesciences (BSE) 1734.15 (2.91%)	M.Cap ( in Cr)23620.30

Shareholding Pattern

	PROMOTERS	58.9%
	NON-INSTITUTION	20.92%
	MUTUAL FUNDS/UTI	18.55%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund-Reg(G)	3.36
Tata India Pharma & Healthcare Fund-Reg(G)	1.65
Tata India Innovation Fund-Reg(G)	0.99
Nippon India Pharma Fund(G)	0.68
DSP Multicap Fund-Reg(G)	0.62
Franklin India Small Cap Fund(G)	0.46
Quant Small Cap Fund(G)	0.45

SIHL House, Opp.Ambawadi Jain Temple, Nehrunagar Cross Roads, Ahmedabad-380015

Prevent Unauthorised transactions in your account. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge as well as for mobile no and for email id updation.Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors".

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NO

SEBI Regn.no. INZ000167335 Member Code: NSE - 07590, BSE Sebi Regn. 943, MCX - 57480 APRN CODE: APRN06051, AMFI ARN: 39843 SEBI Registration No. (DP)- IN-DP-465-2020 NSDL:IN-DP-NSDL-34-97,DP ID:IN300343 CDSL:IN-DP-CSDL-199-2003,DP ID:12029300 Approved person Registration no. with NSDL Database Management Limited(NDML) :IRDA/IR1/2013/004Approved person Registration no. with Center Insurance Repository Limited (CIR): IRDA/IR2/2013/123

REGISTERED ADDRESS:

810, X-Change Plaza, DSCCSL (53E), Road 5E, Block 53, Zone 5, Gift City, Gandhinagar 382050

SHAH INVESTOR'S HOME LTD. CIN NO:-U67120GJ1994PLC023257 SIHL COMMODITIES LTD. CIN NO:-U45201GJ1995PLC025825SIHL CONSULTANCY LTD. CIN NO:-U74140GJ2006PLC049662 SIHL FINCAP LTD.CIN NO:-U65923GJ2006PLC049661 SIHL GLOBAL INVESTMENTS (IFSC) PVT. LTD. CIN NO:-U67190GJ2016PTC094444NSEL MemberCode :10560

CORRESPONDENCE ADDRESS:

SIHL House, Opp. Ambawadi Jain Temple, Nehrunagar Cross Road, Ahmedabad-380015.

For any complains email us at investors@sihl.in Shah Investor's Home Ltd. Member: